Literature DB >> 15515334

Gingival crevicular fluid levels of interleukin-1beta and glycemic control in patients with chronic periodontitis and type 2 diabetes.

Steven P Engebretson1, Judith Hey-Hadavi, Fernando J Ehrhardt, Dan Hsu, Romi S Celenti, John T Grbic, Ira B Lamster.   

Abstract

BACKGROUND: Patients with diabetes have increased incidence and severity of periodontal disease not accounted for by differences in the subgingival microbial infection. Poor glycemic control has been consistently associated with periodontal disease severity. Also, recent evidence suggests that hyperglycemia may induce inflammatory cytokine production. Few studies, however, have examined local biochemical measures of periodontal inflammation in patients with type 2 diabetes. The aim of this study was to determine whether glycemic control was related to gingival crevicular fluid (GCF) levels of interleukin-1beta (IL-1beta).
METHODS: GCF samples were collected from 45 patients with type 2 diabetes and untreated chronic periodontitis. Plaque index (PI), bleeding on probing (BOP), probing depth (PD), and attachment level (AL) were recorded at six sites per tooth. IL-1beta levels were determined from individual GCF samples by enzyme-linked immunoabsorbent assay (ELISA). Individual site and mean patient values were calculated. Glycated hemoglobin (HbA1c) levels were measured from anticoagulated whole blood using an automated affinity chromatography system. Serum glucose was also determined.
RESULTS: Clinical periodontal measures (PD, AL, BOP) and measures of glycemic control (HbA1c, random glucose) were significantly correlated with GCF IL-1beta. Patients with greater than 8% HbA1c had significantly higher mean GCF IL-1beta levels than patients with less than 8% HbA1c. In a multivariate model adjusting for age, gender, PD, AL, BOP, and PI, HbA1c and random glucose were independent predictors of high GCF IL-1beta.
CONCLUSIONS: Poor glycemic control is associated with elevated GCF IL-1beta. These data are consistent with the hypothesis that hyperglycemia contributes to an heightened inflammatory response, and suggests a mechanism to account for the association between poor glycemic control and periodontal destruction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15515334     DOI: 10.1902/jop.2004.75.9.1203

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  37 in total

Review 1.  Diagnostic biomarkers for oral and periodontal diseases.

Authors:  Mario Taba; Janet Kinney; Amy S Kim; William V Giannobile
Journal:  Dent Clin North Am       Date:  2005-07

Review 2.  Novel host response therapeutic approaches to treat periodontal diseases.

Authors:  Keith L Kirkwood; Joni A Cirelli; Jill E Rogers; William V Giannobile
Journal:  Periodontol 2000       Date:  2007       Impact factor: 7.589

3.  Diabetes enhances periodontal bone loss through enhanced resorption and diminished bone formation.

Authors:  R Liu; H S Bal; T Desta; N Krothapalli; M Alyassi; Q Luan; D T Graves
Journal:  J Dent Res       Date:  2006-06       Impact factor: 6.116

Review 4.  Diabetes and periodontal disease: a two-way relationship.

Authors:  L Casanova; F J Hughes; P M Preshaw
Journal:  Br Dent J       Date:  2014-10       Impact factor: 1.626

5.  Levels of proinflammatory chemokines and advanced glycation end products in patients with type-2 diabetes mellitus undergoing fixed orthodontic treatment.

Authors:  Ali Alqerban
Journal:  Angle Orthod       Date:  2021-01-01       Impact factor: 2.079

6.  The effect of photobiomodulation therapy on nonsurgical periodontal treatment in patients with type 2 diabetes mellitus: a randomized controlled, single-blind, split-mouth clinical trial.

Authors:  Seda Sevinç Özberk; Hasan Gündoğar; Mesut Özkaya; İbrahim Levent Taner; Kamile Erciyas
Journal:  Lasers Med Sci       Date:  2019-10-23       Impact factor: 3.161

7.  Hyperglycemia induced and intrinsic alterations in type 2 diabetes-derived osteoclast function.

Authors:  D L Catalfamo; T M Britten; D L Storch; N L Calderon; H L Sorenson; S M Wallet
Journal:  Oral Dis       Date:  2013-04       Impact factor: 3.511

Review 8.  Diabetic complications and dysregulated innate immunity.

Authors:  Dana T Graves; Rayyan A Kayal
Journal:  Front Biosci       Date:  2008-01-01

Review 9.  Therapeutic significance of β-glucuronidase activity and its inhibitors: A review.

Authors:  Paul Awolade; Nosipho Cele; Nagaraju Kerru; Lalitha Gummidi; Ebenezer Oluwakemi; Parvesh Singh
Journal:  Eur J Med Chem       Date:  2019-12-04       Impact factor: 6.514

10.  Biomarkers of oral inflammation in perinatally HIV-infected and perinatally HIV-exposed, uninfected youth.

Authors:  Anna-Barbara Moscicki; Tzy-Jyun Yao; Jonathan S Russell; Sepideh Farhat; Mark Scott; Larry Magpantay; Gordana Halec; Caroline H Shiboski; Mark I Ryder
Journal:  J Clin Periodontol       Date:  2019-09-05       Impact factor: 8.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.